Related references
Note: Only part of the references are listed.Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy
Honglin Tang et al.
ADVANCED MATERIALS (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
PD-1/PD-L1-dependent immune response in colorectal cancer
Zahra Payandeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Daixi Ren et al.
MOLECULAR CANCER (2020)
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
Neda Yaghoubi et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The capability and potential of new forms of personalized colon cancer treatment: Immunotherapy and Photodynamic Therapy
Marta Kaleta-Richter et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2019)
Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
Andre F. Oliveira et al.
FRONTIERS IN ONCOLOGY (2019)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop
Ke Xu et al.
MOLECULAR THERAPY (2019)
High Affinity of Chlorin e6 to Immunoglobulin G for lntraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy
Jiaojiao Xu et al.
ACS NANO (2019)
HIF1 alpha/PD-L1 axis mediates hypoxia-induced cell apoptosis and tumor progression in follicular thyroid carcinoma
Lingyan Zhou et al.
ONCOTARGETS AND THERAPY (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy
Liping Huang et al.
NATURE COMMUNICATIONS (2019)
The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy
Liqin Hu et al.
BIOMATERIALS (2019)
Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma
Lijia Luo et al.
BIOMATERIALS (2019)
Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature
Rui Bao et al.
MOLECULAR PHARMACEUTICS (2019)
In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
Weijing Yang et al.
ACS NANO (2019)
A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy
Yanlei Liu et al.
THERANOSTICS (2019)
Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
Pengfei Kong et al.
JOURNAL OF CANCER (2019)
Fighting Hypoxia to Improve PDT
Ludivine Larue et al.
PHARMACEUTICALS (2019)
Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability
Shotaro Korehisa et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Photodynamic therapy and diagnosis: Principles and comparative aspects
Jane Dobson et al.
VETERINARY JOURNAL (2018)
PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments
Anna Maria Valentini et al.
Oncotarget (2018)
Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al2O3 nanoparticles
Wenfei Chen et al.
THERANOSTICS (2018)
An updated overview on the development of new photosensitizers for anticancer photodynamic therapy
Juan Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Recent advances in nanoparticle carriers for photodynamic therapy
Gawon Yi et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2018)
PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Ramon Cantero-Cid et al.
BMC CANCER (2018)
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
Zeting Yuan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Immunotherapy for colorectal cancer: where are we heading?
Debora Basile et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Targeting integrin-rich tumors with temoporfin-loaded vitamin-E-succinate-grafted chitosan oligosaccharide/D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles to enhance photodynamic therapy efficiency
Junru Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT)
Juanjuan Dang et al.
BIOMATERIALS SCIENCE (2017)
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer
Jun Xu et al.
ACS NANO (2017)
Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy
Yazhe Wang et al.
ACS NANO (2017)
The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy
James W. T. Toh et al.
CLINICAL COLORECTAL CANCER (2016)
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
Xiaopin Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
Yaqi Li et al.
MOLECULAR CANCER (2016)
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy
Dangge Wang et al.
NANO LETTERS (2016)
Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives
Yamin Yang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Current understanding of interactions between nanoparticles and the immune system
Marina A. Dobrovolskaia et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
Chunbai He et al.
NATURE COMMUNICATIONS (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Antitumor immune responses mediated by dendritic cells How signals derived from dying cancer cells drive antigen cross-presentation
Lotte Spel et al.
ONCOIMMUNOLOGY (2013)
Current clinical and preclinical photosensitizers for use in photodynamic therapy
MR Detty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)